ADAM9 and breast cancer: CCK-8 assay demonstrated that overexpression of miR-1298 inhibited the proliferation of BC cells, while re-introduction of ADAM9 significantly attenuated the suppressive role of miR-1298 in both MCF7 and MDA-MB-231 cells (Figure 6B,C).